Latest filings (excl ownership)
15-12G
Securities registration termination
20 Mar 23
EFFECT
Notice of effectiveness
14 Mar 23
EFFECT
Notice of effectiveness
14 Mar 23
EFFECT
Notice of effectiveness
14 Mar 23
EFFECT
Notice of effectiveness
14 Mar 23
EFFECT
Notice of effectiveness
14 Mar 23
S-8 POS
Registration of securities for employees (post-effective amendment)
9 Mar 23
S-8 POS
Registration of securities for employees (post-effective amendment)
9 Mar 23
S-8 POS
Registration of securities for employees (post-effective amendment)
9 Mar 23
S-8 POS
Registration of securities for employees (post-effective amendment)
9 Mar 23
S-8 POS
Registration of securities for employees (post-effective amendment)
9 Mar 23
S-8 POS
Registration of securities for employees (post-effective amendment)
9 Mar 23
POS AM
Prospectus update (post-effective amendment)
9 Mar 23
POS AM
Prospectus update (post-effective amendment)
9 Mar 23
POS AM
Prospectus update (post-effective amendment)
9 Mar 23
POS AM
Prospectus update (post-effective amendment)
9 Mar 23
POS AM
Prospectus update (post-effective amendment)
9 Mar 23
8-K
Completion of Acquisition or Disposition of Assets
9 Mar 23
SC 14D9/A
Tender offer solicitation (amended)
9 Mar 23
25-NSE
Exchange delisting
9 Mar 23
SC TO-T/A
Third party tender offer statement (amended)
9 Mar 23
SC 14D9/A
Tender offer solicitation (amended)
7 Mar 23
SC TO-T/A
Third party tender offer statement (amended)
7 Mar 23
8-K
F-star Therapeutics Announces CFIUS Clearance for Proposed Acquisition by invoX Pharma
7 Mar 23
8-K
Entry into a Material Definitive Agreement
6 Mar 23
SC 14D9/A
Tender offer solicitation (amended)
6 Mar 23
SC TO-T/A
Third party tender offer statement (amended)
6 Mar 23
8-K
Entry into a Material Definitive Agreement
23 Feb 23
SC 14D9/A
Tender offer solicitation (amended)
23 Feb 23
SC TO-T/A
Third party tender offer statement (amended)
23 Feb 23
8-K
Entry into a Material Definitive Agreement
9 Feb 23
SC 14D9/A
Tender offer solicitation (amended)
9 Feb 23
SC TO-T/A
Third party tender offer statement (amended)
9 Feb 23
8-K
Entry into a Material Definitive Agreement
1 Feb 23
SC 14D9/A
Tender offer solicitation (amended)
1 Feb 23
SC TO-T/A
Third party tender offer statement (amended)
1 Feb 23
SC 14D9/A
Tender offer solicitation (amended)
18 Jan 23
SC TO-T/A
Third party tender offer statement (amended)
18 Jan 23
8-K
Entry into a Material Definitive Agreement
30 Dec 22
SC 14D9/A
Tender offer solicitation (amended)
30 Dec 22
Latest ownership filings
SC 13G
Beryl Capital Management LLC
17 Mar 23
4
Louis Kayitalire
9 Mar 23
4
Eliot Forster
9 Mar 23
4
Pamela M. Klein
9 Mar 23
4
DARLENE M DEPTULA-HICKS
9 Mar 23
4
Todd C Brady
9 Mar 23
4
Neil Brewis
9 Mar 23
4
Geoffrey Race
9 Mar 23
4
Nessan Bermingham
9 Mar 23
4
Edward Benz JR
9 Mar 23
4
David Arkowitz
9 Mar 23
SC 13G/A
Ridgeback Capital Investments L.P.
14 Feb 23
SC 13G/A
Ridgeback Capital Investments L.P.
14 Feb 23
4
Geoffrey Race
9 Jan 23
4
Eliot Forster
2 Aug 22
4
Neil Brewis
2 Aug 22
4
Todd C Brady
22 Jun 22
4
Geoffrey Race
22 Jun 22
4
Edward Benz JR
22 Jun 22
4
Pamela M. Klein
22 Jun 22
4
Nessan Bermingham
22 Jun 22
4
David Arkowitz
22 Jun 22
4
Eliot Forster
4 Apr 22
4
DARLENE M DEPTULA-HICKS
4 Apr 22
4
Louis Kayitalire
4 Apr 22
4
Neil Brewis
4 Apr 22
SC 13G/A
Rock Springs Capital Management LP
15 Feb 22
SC 13G/A
Ridgeback Capital Investments L.P.
14 Feb 22
SC 13G/A
Point72 Asset Management, L.P.
14 Feb 22
SC 13G/A
Boxer Capital, LLC
14 Feb 22
SC 13G/A
Atlas Venture Opportunity Fund I, L.P.
14 Feb 22
SC 13G/A
GLAXOSMITHKLINE PLC
10 Feb 22
SC 13G/A
Merck KGaA
8 Feb 22
4
Louis Kayitalire
11 Jan 22
4
DARLENE M DEPTULA-HICKS
11 Jan 22
4
Neil Brewis
11 Jan 22
4
Eliot Forster
11 Jan 22
4
Louis Kayitalire
4 Nov 21
4
Louis Kayitalire
6 Oct 21
4/A
Nessan Bermingham
24 Aug 21